Literature DB >> 6416717

Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly.

A J Clark, P Chahal, K Mashiter, G F Joplin.   

Abstract

We have investigated the possibility that the increase in serum PRL levels observed in patients with acromegaly treated with external irradiation could be due to damage to the hypothalamus or portal vessels, by comparing the effects of yttrium-90 interstitial irradiation, which is highly localised and does not normally extend to the hypothalamus, in a similar series of patients. Sixteen acromegalic patients treated by interstitial irradiation with yttrium-90 are described; GH fell from a mean of 131 mU/l (median 113 mU/l) to 17 mU/l (median 8 mU/l) after one year (P less than 0.001). PRL fell in the five initially hyperprolactinaemic patients (mean fall +/- SD: 39 +/- 17 micrograms/l at one year), but remained unchanged in the normoprolactinaemic group; PRL responsiveness to TRH was retained. Five, out of the seven normoprolactinaemic patients examined, were shown by in vitro studies of their pituitary biopsies, to have tumours that also synthesised or secreted PRL. These results are consistent with the hypothesis that the rise in PRL following external irradiation is the result of damage to the hypothalamus or portal vessels. A less likely explanation is that an overgrowth of radio-resistant PRL-secreting tumour cells is occurring after external irradiation, but not after yttrium-90 implantation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6416717     DOI: 10.1111/j.1365-2265.1983.tb00031.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Circadian and pulsatile thyrotropin release in treated acromegalics.

Authors:  F Roelfsema; H de Boer; M Frölich
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Effect of radiation on the human reproductive system.

Authors:  A L Ogilvy-Stuart; S M Shalet
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.